The CDT uses studies of childhood diseases and development to identify mechanisms and principles that can be translated into children’s health improvements.
The Neonatal Respiratory Support Technologies team has developed Seattle Positive Airway Pressure (Seattle-PAP), an invention that promises to... cont.
Many drugs and treatments are made for – and tested on – adults. We’re making sure they’re as safe as possible for kids.
Dr. Michael Portman is unraveling how the heart responds to injury, and identifying supplements that prevent damage and accelerate recovery.
Help us answer questions about childhood health and illness, and help other children in the future.
Reproducibility: In praise of open research measures. Nature. 2013 Jun 13;498 (7453):170. doi: 10.1038/498170b. Kolker E.
Prepregnancy body mass index and congenital heart defects among offspring: a population-based study. Congenit Heart Dis. 2013 Mar-Apr;8 (2):131-41. doi: 10.1111/j.1747-0803.2012.00714.x. Epub 2012 Sep 12. Madsen NL, Schwartz SM, Lewin MB, Mueller BA.
Kawasaki disease and soy: potential role for isoflavone interaction with Fcγ receptors. Pediatr Res. 2013 Feb;73 (2):130-4. doi: 10.1038/pr.2012.168. Epub 2012 Nov 20. Portman MA.
C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle. J Mol Cell Cardiol. 2013 Feb;55:156-64. doi: 10.1016/j.yjmcc.2012.07.005. Olson AK, Ledee D, Iwamoto K, Kajimoto M, O'Kelly Priddy C, Isern N, Portman MA.
Email the CDT
1900 Ninth Avenue
Seattle, WA 98101
PO Box 5371
Seattle, WA 98145-5005
More than half of the kids who come to Seattle Children’s live with serious conditions that they will have for the rest of their lives. Research can give them a different future. Your support makes it possible.